The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
remember when you block sglt2 you're preventing the kidney from reabsorbing not just glucose but sodium so as a patient is excreting more glucose and sodium in their urine you would think they have obviously less sodium within their plasma that may explain the the benefits we see on the blood pressure front as well
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
I think it probably has to do with the reduction in blood pressure